GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Pyxis Stock Craters 46% Amid Phase 1 Data, William Blair Downgrade
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields
Novo-nordisk a/s stock price returns to the starting point of the year! Sales of weight loss medication fall short of expectations, scaring off investors.
①Danish pharmaceutical company novo-nordisk a/s saw its stock price drop by over 40% from the year's high due to intensified competition in the weight loss drug market, supply restrictions, and financial reports falling below expectations; ② Novo Nordisk's CFO admitted that next year's sales growth rate may be in the tens of percent, significantly lagging behind market expectations; ③ Analysts believe that the current excessive selling sentiment towards weight loss drugs, the company still has high investment value.
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today
CDC Warns Against a Spike in COVID, Flu Cases